Marco Zanotto

623 total citations
13 papers, 489 citations indexed

About

Marco Zanotto is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Marco Zanotto has authored 13 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Marco Zanotto's work include Cancer, Hypoxia, and Metabolism (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Cancer Cells and Metastasis (3 papers). Marco Zanotto is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Cancer Cells and Metastasis (3 papers). Marco Zanotto collaborates with scholars based in Italy and United States. Marco Zanotto's co-authors include Geny Piro, Davide Melisi, Carmine Carbone, Giampaolo Tortora, Raffaela Santoro, Giorgio Malpeli, Omar Perbellini, Francesco Bifari, Marco Chilosi and Mario Ricciardi and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Marco Zanotto

13 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Zanotto Italy	9	254	221	134	118	85	13	489
Benjamin L. Bryson United States	12	287 1.1×	354 1.6×	98 0.7×	150 1.3×	79 0.9×	17	584
Shao‐Lan Qin China	13	179 0.7×	269 1.2×	93 0.7×	140 1.2×	53 0.6×	26	482
Ruiqing Peng China	12	160 0.6×	293 1.3×	99 0.7×	183 1.6×	79 0.9×	27	503
Zhenbo Tu China	14	158 0.6×	328 1.5×	106 0.8×	237 2.0×	82 1.0×	22	520
Xianshuo Cheng China	12	250 1.0×	244 1.1×	133 1.0×	211 1.8×	76 0.9×	26	552
Carlotta Raschioni Italy	9	201 0.8×	284 1.3×	141 1.1×	158 1.3×	49 0.6×	11	566
Agnes Csiszar Austria	8	227 0.9×	205 0.9×	108 0.8×	92 0.8×	44 0.5×	12	428
Guangyan Zhangyuan China	13	113 0.4×	349 1.6×	97 0.7×	219 1.9×	70 0.8×	16	549
Minna Shen China	9	203 0.8×	209 0.9×	80 0.6×	208 1.8×	71 0.8×	22	520
Hee-Jung Byun South Korea	8	128 0.5×	254 1.1×	102 0.8×	106 0.9×	29 0.3×	8	477

Countries citing papers authored by Marco Zanotto

Since Specialization

Citations

This map shows the geographic impact of Marco Zanotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Zanotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Zanotto more than expected).

Fields of papers citing papers by Marco Zanotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Zanotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Zanotto. The network helps show where Marco Zanotto may publish in the future.

Co-authorship network of co-authors of Marco Zanotto

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Zanotto. A scholar is included among the top collaborators of Marco Zanotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Zanotto. Marco Zanotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Santoro, Raffaela, Marco Zanotto, Francesca Simionato, et al.. (2019). Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer. Molecular Cancer Therapeutics. 19(1). 247–257. 47 indexed citations

Santoro, Raffaela, Marco Zanotto, Carmine Carbone, et al.. (2018). MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity. Anticancer Research. 38(4). 1937–1946. 41 indexed citations

Santoro, Raffaela, Marco Zanotto, Geny Piro, et al.. (2018). Abstract 3339: Modulating TAK1 expression through the inhibition of GSK3 impairs YAP/TAZ oncogenic functions in pancreatic cancer. Cancer Research. 78(13_Supplement). 3339–3339. 2 indexed citations

Carbone, Carmine, Geny Piro, Francesca Simionato, et al.. (2017). Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients. Clinical Cancer Research. 23(15). 4312–4322. 41 indexed citations

Piro, Geny, Carmine Carbone, Ivana Cataldo, et al.. (2016). An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients. Clinical Cancer Research. 22(24). 6164–6175. 68 indexed citations

Carbone, Carmine, Geny Piro, Francesca Simionato, et al.. (2016). Abstract 3265: Homeobox B9 (HOXB9) sustains anti-VEGF treatment resistance in gastrointestinal tumors. Cancer Research. 76(14_Supplement). 3265–3265. 1 indexed citations

Carbone, Carmine, Anna Tamburrino, Geny Piro, et al.. (2015). Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment. Anti-Cancer Drugs. 27(1). 29–40. 31 indexed citations

Ricciardi, Mario, Marco Zanotto, Giorgio Malpeli, et al.. (2015). Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. British Journal of Cancer. 112(6). 1067–1075. 143 indexed citations

Piro, Geny, Simone Giacopuzzi, Maria Bencivenga, et al.. (2015). TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients. British Journal of Cancer. 113(6). 878–885. 29 indexed citations

10.

Ricciardi, Mario, Marco Zanotto, Giorgio Malpeli, et al.. (2015). Epithelial-to-mesenchymal transition (EMT) elicits mesenchymal stromal cell-like immune modulatory properties in cancer cells. Cytotherapy. 17(6). S20–S20. 1 indexed citations

11.

Melisi, Davide, Melissa Frizziero, Anna Tamburrino, et al.. (2014). Toll-Like Receptor 9 Agonists for Cancer Therapy. Biomedicines. 2(3). 211–228. 32 indexed citations

12.

Carbone, Carmine, Geny Piro, Matteo Fassan, et al.. (2014). An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis. Oncotarget. 6(15). 13822–13834. 50 indexed citations

13.

Ricciardi, Mario, Martina Midolo, Giulio Bassi, et al.. (2013). Comparison Between Bone Marrow Mesenchymal Stromal Cells (BM-MSC) and Lung Mesenchymal Stromal Cells (Lung-MSC) For Epithelial Regeneration. Blood. 122(21). 5414–5414. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact